Indian pharmaceutical companies in China run into a wall, but optimistic about f
India Pharmaceutical companies Rapid progress in the global market, but they have hit a wall in China.
Ranbaxy Inc. (RanbaxyLaboratories) is India's largest pharmaceutical company, is also the first Indian pharmaceutical company to enter China in 1993 to set up a joint venture in China. But last December, it gave up joint venture companies. Although it has invested millions of rupees, has developed more than 40 products.
Failure is: a strong market access barriers, time-consuming long commercial infrastructure, as well as the cost of China's domestic pharmaceutical companies failing in the competition. Dr. Reddy
company (DrReddy'sLaboratories) is India's second-largest drug maker, the company's executive director and chief operating SatishReddy said, "China's market to the global generic drug manufacturers and foreign pharmaceutical companies has always been a challenge."
So, while Indian pharmaceutical companies in the past two decades, occupying a range of global Drugs Market, but so far, has not been able to open the Chinese market. Although in the past 7 years, China's pharmaceutical market grew by more than 3 times in fact. And is expected in the next 2-3 years, will become the United States and Japan after the world's third largest pharmaceutical market.
Indian Orchid Medicine Chemical industry Co., Ltd. (OrchidChemicals & Pharmaceuticals) is entered China in 2003, a joint venture in China's major Sell Antibiotic And cephalosporins agents, have been no major progress. 7 years later, the profits of the venture is only about 200-400 million dollars, less than 4 million U.S. dollars turnover.
The company spokesman ChRam said, "In China, the need for sub-areas of proprietary products, and China's domestic pharmaceutical competition."
Another Indian pharmaceutical company Rubin (Lupin), has come to China for many years, but not the production of pharmaceuticals in China, the company spokesman said. Rubin refused to reveal revenue from China.
"And the China Pharmaceutical Business Cooperation Language is an important issue, without local partners, sell products in China, it is impossible ", the Indian Pharmaceutical Alliance (CIPI) Chairman TSJaishankar said.
PricewaterhouseCoopers India, said deputy director of SujayShetty to find trusted partners and in a highly regulated market to establish branches in China of foreign enterprises is an important issue.
According to data provider Wicon Medicine estimated in 2007 the total size of China's pharmaceutical market is about 50 billion U.S. dollars. China has about 3,500 local pharmaceutical companies, accounting for more than 70% market share. China's top ten companies accounted for 20% share. Orchid Chemicals Ltd., India medical
(OrchidChemicals & Pharmaceuticals) entered China in 2003, a joint venture in China, mainly antibiotics and cephalosporins sales agents, have been no major progress. 7 years later, the profits of the venture is only about 200-400 million dollars, less than 4 million U.S. dollars turnover.
The company spokesman ChRam said, "In China, the need for sub-areas of proprietary products, and China's domestic pharmaceutical competition."
Another Indian pharmaceutical company Rubin (Lupin), has come to China for many years, but not the production of pharmaceuticals in China, the company spokesman said. Rubin refused to reveal revenue from China.
We are high quality suppliers, our products such as E1/V.35 converter , china Optical Ethernet Switch for oversee buyer. To know more, please visits fiber optic modem.
Processing your request, Please wait....
